The prevalence of gastroesophageal reflux disease (GERD) has mirrored the increase in obesity, and GERD is now recognized as an obesity-related comorbidity. There is growing evidence that obesity, specifically central obesity, is associated with the complications of chronic reflux, including erosive esophagitis, Barrett's esophagus, and esophageal adenocarcinoma. While fundoplication is effective in creating a competent gastroesophageal junction and controlling reflux in most patients, it is less effective in morbidly obese patients. In these patients a bariatric operation has the ability to correct both the obesity and the abnormal reflux. The Roux-en-Y gastric bypass is the preferred procedure.
Get full access to this article
View all access options for this article.
References
1.
FlegalKM, CarrollMD, KitBK, OgdenCL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA, 2012; 307:491.
2.
OgdenCL, CarrollMD, KitBK, FlegalKM. Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA, 2014; 311:806.
3.
PattersonEJ, DavisDG, KhajancheeY, SwanstromLL: Comparison of objective outcomes following laparoscopic Nissen fundoplication versus laparoscopic gastric bypass in the morbidly obese with heartburn. Surg Endosc, 2003; 17: 1561–1565.
4.
El-SeragHB, SweetS, WinchesterCCet al.Update on the epidemiology of gastro-oesophageal reflux disease: A systematic review. Gut, 2014; 43:161–173.
5.
NadaletoBF, HerbellaFAM, PattiMG. Gastroesophageal reflux disease in the obese: Pathophysiology and treatment, Surgery, 2016; 159:475–486.
6.
LeeHL, EunCS, LeeOY, et al.Association between GERD-related erosive esophagitis and obesity. J Clin Gastroenterol, 2008; 42:672–675.
7.
CorleyDA, KuboA, LevinTR, et al.Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology, 2007; 133:34–41.
8.
HoyoC, CookMB, KamangarF, et al.Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: A pooled analysis from the International BEACON Consortium. Int J Epidemiol, 2012; 41:1706–1718.
9.
PrachandVN, AlverdyJC. Gastroesophageal reflux disease and severe obesity: Fundoplication or bariatric surgery?. World J Gastroenterol, 2010; 16:3757–3761.
10.
ValeziAC, HerbellaFA, MaliJJr.Gastroesophageal reflux disease: Pathophysiology. In: FisichellaPM, AllaixME, MorinoM, PattiMG (eds). Esophageal Disease. Evaluation and Treatment. New York: Springer, 2014, pp. 41–51.
11.
HongD, KhajancheeYS, PereiraN, LockhartB, PattersonEJ, SwanstromLL. Manometric abnormalities and gastroesophageal reflux disease in the morbidly obese. Obes Surg, 2004; 14:744–749.
12.
SuterM, DortaG, GiustiV, CalmesJM. Gastro-esophageal reflux and esophageal motility disorders in morbidly obese patients. Obes Surg, 2004; 14:959–966.
13.
MurrayL, JohnstonB, LaneA, et al.Relationship between body mass and gastro-oesophageal reflux symptoms: The Bristol Helicobacter Project. Int J Epidemiol, 2003; 32:645–650.
14.
RuhlCE, EverhartJE. Overweight, but not high dietary fat intake, increases risk of gastroesophageal reflux disease hospitalization: The NHANES I Epidemiologic Followup Study. Ann Epidemiol, 1999; 9:424–435.
KahrilasPJ, ShiG, MankaM, et al.Increased frequency of transient lower esophageal sphincter relaxation induced by gastric distention in reflux patients with hiatal hernia. Gastroenterology, 2000; 118:688–695.
27.
FisherBL, PennathurA, MutnickJL, et al.Obesity correlates with gastroesophageal reflux. Dig Dis Sci, 1999; 44:2290–2294.
28.
SugermanHJ, DeMariaEJ, Felton WLIII, NakatsukaM, SismanisA. Increased intra-abdominal pressure and cardiac filling pressures in obesity-associated pseudotumor cerebri. Neurology, 1997; 49:507–511.
29.
VarelaJE, HinojosaM, NguyenN. Correlations between intra-abdominal pressure and obesity related co-morbidities. Surg Obes Relat Dis, 2009; 5:524–528.
30.
El-SeragHB, TranT, RichardsonP, et al.Anthropometric correlates of intragastric pressure. Scand J Gastroenterol, 2006; 41:887–891.
31.
MercerCD, WrenSF, DaCostaLR, BeckIT. Lower esophageal sphincter pressure and gastroesophageal pressure gradients in excessively obese patients. J Med, 1987; 18:135–146.
32.
WisenO, RossnerS, JohanssonC. Impaired pancreatico-biliary response to vagal stimulation and to cholecystokinin in human obesity. Metabolism, 1988; 37:436–441.
33.
CatarciM, GentileschiP, PapiC, CarraraA, MarreseR, Gaspari AL, Grassi GB. Evidence-based appraisal of antireflux fundoplication. Ann Surg, 2004; 239:325–337.
34.
DallemagnB, WeertsJ, MarkiewiczS, et al.Clinical results of laparoscopic fundoplication at ten years after surgery. Surg Endosc, 2006; 20:159–165.
35.
SalminenPT, HiekkanenHI, RantalaAP, OvaskaJT. Comparison of long-term outcome of laparoscopic and conventional nissen fundoplication: A prospective randomized study with an 11-year follow-up. Ann Surg, 2007; 246:201–206.
36.
VarinO, VelstraB, De SutterS, CeelenW. Total vs partial fundoplication in the treatment of gastroesophageal reflux disease: A meta-analysis. Arch Surg, 2009; 144:273–278.
GalvaniC, FisichellaPM, GorodnerMV, PerrettaS, PattiMG. Symptoms are a poor indicator of reflux status after fundoplication for gastroesophageal reflux disease: Role of esophageal functions tests. Arch Surg, 2003; 138:514–518.
39.
CamposGM, PetersJH, DeMeesterTR, et al.Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication. J Gastrointest Surg, 1999; 3:292–300.
40.
PattiMG. An evidence-based approach to the treatment of gastroesophageal reflux disease. JAMA, 2016; 151:73–78.
41.
PerezAR, MoncureAC, RattnerDW. Obesity is a major cause of failure for both transabdominal and transthoracic antireflux operations. Abstract 2109. Presented at the Society for Surgery of the Alimentary Tract, Digestive Disease Week, 1999.
42.
MorgenthalCB, LinE, ShaneMD, et al.Who will fail laparoscopic Nissen fundoplication? Preoperative prediction of long-term outcomes. Surg Endosc, 2007; 21:1978–1984.
43.
AkimotoS, NandipatiKC, KapoorH, et al.Association of body mass index (BMI) with patterns of fundoplication failure: Insights gained. J Gastrointest Surg, 2015; 19:1943–1948.
44.
AnvariM, BamehrizF. Outcome of laparoscopic Nissen fundoplication in patients with body mass index >or = 35. Surg Endosc, 2006; 20:230–234.
45.
WinslowER, FrisellaMM, SoperNJ, KlingensmithME. Obesity does not adversely affect the outcome of laparoscopic antireflux surgery (LARS). Surg Endosc, 2003; 17:2003–2011.
46.
ChisholmJA, JamiesonGG, LallyCJ, DevittPG, GamePA, WatsonDI. The effect of obesity on the outcome of laparoscopic antireflux surgery. J Gastrointest Surg, 2009; 13:1064–1070.
47.
D'AlessioMJ, ArnaoutakisD, GiarelliN, VilladolidDV, RosemurgyAS. Obesity is not a contraindication to laparoscopic Nissen fundoplication. J Gastrointest Surg, 2005; 9:949–954.
48.
HesselinkVJ, LuijendijkRW, de WiltJH, HeideR, JeekelJ. An evaluation of risk factors in incisional hernia recurrence. Surg Gynecol Obstet, 1993; 176:228–234.
49.
SauerlandS, KorenkovM, KleinenT, ArndtM, PaulA. Obesity is a risk factor for recurrence after incisional hernia repair. Hernia, 2004; 8:42–46.
50.
SchauerPR, IkramuddinS, GourashW, RamanathanR, LuketichJ. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg, 2000; 232:515–529.
51.
BuchwaldH, AvidorY, BraunwaldE, JensenMD, PoriesW, FahrbachK, SchoellesK. Bariatric surgery: A systematic review and meta-analysis. JAMA, 2004; 292:1724–1737.
52.
JonesKBJr.Roux-en-Y gastric bypass: An effective antireflux procedure in the less than morbidly obese. Obes Surg, 1998; 8:35–38.
53.
KelloggTA, AndradeR, MaddausM, SlusarekB, BuchwaldH, IkramuddinS. Anatomic findings and outcomes after antireflux procedures in morbidly obese patients undergoing laparoscopic conversion to Roux-en-Y gastric bypass. Surg Obes Relat Dis, 2007; 3:52–57; discussion 58–59.
54.
DixonJB, O'BrienPE. Gastroesophageal reflux in obesity: The effect of lap-band placement. Obes Surg, 1999; 9:527–531.
ReynoldsJL, ZehetnerJ, ShiragaS, LiphamJC, KatkhoudaN. Intraoperative assessment of the effects of laparoscopic sleeve gastrectomy on the distensibility of the lower esophageal sphincter using impedance planimetry. Surg Endosc, 2016; 30:4904:4909.
57.
ValeziAC, HerbellaFA, JuniorJM, de Almeida MenezesM. Esophageal motility after laparoscopic Roux-en-Y gastric bypass: The manometry should be preoperative examination routine?. Obes Surg, 2012; 22:1050–1054.
58.
Ness-JensenA, LindamA, LagergrenJ, HveemK. Weight loss and reduction in gastroesophageal reflux. A prospective population-based cohort study: The HUNT stud. Am J Gastroenterol, 2013; 108:376–382.
59.
Fraser-MoodieCA, NortonB, GornallC, MagnagoS, WealeAR, HolmesGK. Weight loss has an independent beneficial effect on symptoms of gastro-oesophageal reflux in patients who are overweight. Scand J Gastroenterol, 1999; 34:337–340.
60.
Mathus-VliegenEM, van WeerenM, van EertenPV. LOS function and obesity: The impact of untreated obesity, weight loss, and chronic gastric balloon distension. Digestion, 2003; 68:161–168.
61.
Mathus-VliegenEM, TygatGN. Gastro-oesophageal reflux in obese subjects: Influence of overweight, weight loss and chronic gastric balloon distension. Scand J Gastroenterol, 2002; 37: 1246–1252
62.
SinghM, LeeJ, GuptaN, GaddamS, SmithBK, WaniSB, et al.Weight loss can lead to resolution of gastroesophageal reflux disease symptoms: A prospective intervention trial. Obesity (Silver Spring), 2013; 21:284–290.
63.
KnowlerWC, Barrett-ConnorE, FowlerSE, et al.Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med, 2002; 346:393.
64.
LeblancES, O'ConnorE, WhitlockEP, et al.Effectiveness of primary care-relevant treatments for obesity in adults: A systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med, 2011; 155:434.
65.
JensenMD, RyanDH, ApovianCM, et al.2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol, 2014; 63:2985.
66.
VarelaJE, HinojosaMW, NguyenNT. Laparoscopic fundoplication compared with laparoscopic gastric bypass in morbidly obese patients with gastroesophageal reflux disease. Surg Obes Relat Dis, 2009; 5:139–143.
67.
MadalossoCA, GurskiRR, Callegari-JacquesSM, NavariniD, ThiesenV, FornariF. The impact of gastric bypass on gastroesophageal reflux disease in patients with morbid obesity: A prospective study based on the Montreal Consensus. Ann Surg, 2010; 251:244–248.
NelsonLG, GonzalezR, HainesK, GallagherSF, MurrMM. Amelioration of gastroesophageal reflux symptoms following Roux-en-Y gastric bypass for clinically significant obesity. Am Surg, 2005; 71:950–953; discussion 953–954.
70.
OrtegaJ, EscuderoMD, MoraF, et al.Outcome of esophageal function and 24-hour esophageal pH monitoring after vertical banded gastroplasty and Roux-en-Y gastric bypass. Obes Surg, 2004; 14:1086–2004.
71.
BergerEH. The distribution of parietal cells in the stomach: A histotopographic study. Am J Anat, 1934; 54:87–114.
72.
DeMariaEJ. Bariatric surgery for morbid obesity. N Engl J Med, 2007; 356:2176–2183.
73.
SmithSC, EdwardsCB, GoodmanGN. Symptomatic and clinical improvement in morbidly obese patients with gastroesophageal reflux disease following Roux-en-Y gastric bypass. Obes Surg, 1997; 7:479–484.
74.
NaikRD, ChoksiYA, VaeziMF. Impact of weight loss surgery on esophageal physiology. Gastroenterol Hepatol (N Y), 2015; 11:801–809.
75.
De GrootNL, BurgerhartJS, Van De MeebergPC, de VriesDr, SmoutAJ, SiersemaPD. Systematic review: The effects of conservative and surgical treatment for obesity on gastro-oesophageal reflux disease. Aliment Pharmacol Ther, 2009; 30:1091–1102.
Mejía-RivasMA, Herrera-LópezA, Hernández-CallerosJ, HerreraMF, ValdovinosMA. Gastroesophageal reflux disease in morbid obesity: The effect of Roux-en-Y gastric bypass. Obes Surg, 2008; 18:1217–1224.
78.
SugermanH, WindsorA, BessosM, et al.Effects of surgically induced weight loss on urinary bladder pressure, sagittal abdominal diameter and obesity co-morbidity. Int J Obes Relat Metab Disord, 1998; 22:230–235.
79.
ScopinaroN, AdamiGF, MarinariGM, et al.Biliopancreatic diversion. World J Surg, 1998; 22:935–946.
BaltasarA, BouR, BengocheaM, et al.Duodenal switch: An effective therapy for morbid obesity-intermediate results. Obes Surg, 2001; 11:54–58.
82.
PrachandVN, WardM, AlverdyJC. Duodenal switch provides superior resolution of metabolic comorbidities independent of weight loss in the super-obese (BMI > or = 50 kg/m2) compared with gastric bypass. J Gastrointest Surg, 2010; 14:211–220.
83.
RebecchiF, AllaixME, GiacconeC, UglionoE, ScozzariG, MorinoM. Gastroesophageal reflux disease and laparoscopic sleeve gastrectomy: A physiopathologic evaluation. Ann Surg, 2014; 260:909–914; discussion 914–915.
84.
GorodnerV, BuxhoevedenR, ClementeG, SoléL, CaroL, GrigaitesA. Does laparoscopic sleeve gastrectomy have any influence on gastroesophageal reflux disease? Preliminary results. Surg Endosc, 2015; 29:1760–1768.
85.
ChiuS, BirchDW, ShiX, et al.Effect of sleeve gastrectomy on gastroesophageal reflux disease: A systematic review. Surg Obes Relat Dis, 2011; 7:510–515.
86.
OorJE, RoksDJ, CagdusU, HazebroekEJ. Laparoscopic sleeve gastrectomy and gastroesophageal reflux disease: A systematic review and meta-analysis. Am J Surg, 2016; 211:250–267.
87.
HinojosaMW, VarelaJE, ParikhD, et al.National trends in use and outcome of laparoscopic adjustable gastric banding. Surg Obes Relat Dis, 2009; 5:150–155.
88.
HimpensJ, CadièreG-B, BaziM, et al.Long-term outcomes of laparoscopic adjustable gastric banding. Arch Surg, 2011; 146:802–807.
89.
DangJT, SwitzerNG, WuJ, et al.Gastric band removal in a revisional bariatric surgery, one-step versus two-step: A systematic review and meta-analysis. Obes Surg, 2016; 26:866–873.
90.
GagnerM, GumbsAA. Gastric banding: Conversion to sleeve, bypass, or DS. Surg Endosc, 2007; 21:1931–1935.
91.
DeMariaEJ, SugermanHJ, MeadorJG, et al.High failure rate after laparoscopic adjustable silicone gastric banding for treatment of morbid obesity. Ann Surg, 2001; 233:809.
92.
AngrisaniL, IovinoP, LorenzoM, SantoroT, SabbatiniF, ClaarE, NicodemiO, PersicoG, TesauroB. Treatment of morbid obesity and gastroesophageal reflux with hiatal hernia by Lap-Band. Obes Surg, 1999; 9:396–398.
93.
LovinoP, AngrisaniL, TremolaterraF, NirchioE, CiannellaM, BorrelliV, SabbatiniF, MazzaccaG, CiacciC. Abnormal esophageal acid exposure is common in morbidly obese patients and improves after a successful Lap-band system implantation. Surg Endosc, 2002; 16:1631–1635.
94.
SuterM, DortaG, GiustiV, CalmesJM. Gastric banding interferes with esophageal motility and gastroesophageal reflux. Arch Surg, 2005; 140:639–643.
95.
KlausA, GruberI, WetscherG, NehodaH, AignerF, PeerR, MargreiterR, WeissH. Prevalent esophageal body motility disorders underlie aggravation of GERD symptoms in morbidly obese patients following adjustable gastric banding. Arch Surg, 2006; 141:247–251.
96.
GutschowCA, ColletP, PrenzelK, HölscherAH, SchneiderPM. Long-term results and gastroesophageal reflux in a series of laparoscopic adjustable gastric banding. J Gastrointest Surg, 2005; 9:941–948.
97.
MerroucheM, SabatéJM, JouetP, et al.Gastro-esophageal reflux and esophageal motility disorders in morbidly obese patients before and after bariatric surgery. Obes Surg, 2007; 17:894–900.
98.
PallatiPK, ShaligramA, ShostromVK, OleynikovD, McBrideCL, GoedeMR. Improvement in gastroesophageal reflux disease symptoms after various bariatric procedures: Review of the Bariatric Outcomes Longitudinal Database. Surg Obes Relat Dis, 2014; 10:502–507.
99.
PeterliR, BorbélyY, KernB, GassM, PetersT, ThurnheerM, SchultesB, LaederachK, BueterM, SchiesserM. Early results of the Swiss Multicentre Bypass or Sleeve Study (SM-BOSS): A prospective randomized trial comparing laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass. Ann Surg, 2013; 258:690–694.
